CoChat

An Improved Model for Disease Progression in Patients From the Alzheimer's Disease Neuroimaging Initiative

Samtani, Mahesh N., Farnum, Michael, Lobanov, Victor, Yang, Eric, Raghavan, Nandini, DiBernardo, Allitia, Narayan, Vaibhav, And the Alzheimer's Disease Neuroimaging Initiative · 2012 · The Journal of Clinical Pharmacology
Cited by 80

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

The objective of this analysis was to develop a semi‐mechanistic nonlinear disease progression model using an expanded set of covariates that captures the longitudinal change of Alzheimer's Disease Assessment Scale (ADAS‐cog) scores from the Alzheimer's Disease Neuroimaging Initiative study that consisted of 191 Alzheimer disease patients who were followed for 2 years. The model describes the rate of progression and baseline disease severity as a function of influential covariates. The covariates that were tested fell into 4 categories: (1) imaging volumetric measures, (2) serum biomarkers, (3) demographic and genetic factors, and (4) baseline cognitive tests. Covariates found to affect baseline disease status were years since disease onset, hippocampal volume, and ventricular volume. Disease progression rate in the model was influenced by age, total cholesterol, APOE ε4 genotype, Trail Making Test (part B) score, and current levels of impairment as measured by ADAS‐cog. Rate of progression was slower for mild and severe Alzheimer patients compared with moderate Alzheimer patients who exhibited faster rates of deterioration. In conclusion, this model describes disease progression in Alzheimer patients using novel covariates that are important for understanding the worsening of ADAS‐cog scores over time and may be useful in the future for optimizing study designs through clinical trial simulations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0091270011405497

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 80

Metadata

Authors
Samtani, M. N., Farnum, M., Lobanov, V., Yang, E., Raghavan, N., DiBernardo, A., Narayan, V., & Initiative, A. T. A. D. N.
Venue
The Journal of Clinical Pharmacology
Publisher
Wiley
Published
2012-05
Volume
52
Issue
5
Pages
629-644
ISSN
  • 0021-9754 (ISSN-L)
  • 0091-2700
  • 1552-4604
OpenAlex
W1969313677
Cited by
80
References
6
FWCI
5.71
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An Improved Model for Disease Progression in Patients From the Alzheimer's Disease Neuroimaging Initiative. https://app.cochat.ai/papers/10.1177/0091270011405497
The paper
Samtani, M. N., Farnum, M., Lobanov, V., Yang, E., Raghavan, N., DiBernardo, A., Narayan, V., & Initiative, A. T. A. D. N. (2012). An Improved Model for Disease Progression in Patients From the Alzheimer's Disease Neuroimaging Initiative. The Journal of Clinical Pharmacology. https://doi.org/10.1177/0091270011405497

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.